Profile | GDS5420 / 241734_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 534.25 | 68 |
GSM1296119 | B_lesional_pre-dose | 1016.93 | 80 |
GSM1296076 | C_lesional_pre-dose | 1120.65 | 81 |
GSM1296092 | D_lesional_pre-dose | 688.36 | 73 |
GSM1296103 | E_lesional_pre-dose | 507.96 | 68 |
GSM1296078 | F_lesional_pre-dose | 923.52 | 78 |
GSM1296107 | G_lesional_pre-dose | 932.96 | 78 |
GSM1296109 | H_lesional_pre-dose | 536.26 | 68 |
GSM1296080 | I_lesional_pre-dose | 418.62 | 65 |
GSM1296090 | J_lesional_pre-dose | 682.75 | 73 |
GSM1296074 | K_lesional_pre-dose | 834.23 | 76 |
GSM1296111 | L_lesional_pre-dose | 1118.76 | 81 |
GSM1296099 | M_lesional_pre-dose | 597.57 | 70 |
GSM1296086 | O_lesional_pre-dose | 760.19 | 75 |
GSM1296117 | P_lesional_pre-dose | 989.41 | 79 |
GSM1296113 | Q_lesional_pre-dose | 1001.01 | 80 |
GSM1296096 | R_lesional_pre-dose | 631.02 | 71 |
GSM1296105 | S_lesional_pre-dose | 558.02 | 69 |
GSM1296098 | T_lesional_pre-dose | 383.58 | 63 |
GSM1296101 | U_lesional_pre-dose | 436.92 | 65 |
GSM1296121 | V_lesional_pre-dose | 924.46 | 78 |
GSM1296088 | W_lesional_pre-dose | 612.45 | 71 |
GSM1296082 | X_lesional_pre-dose | 760.52 | 75 |
GSM1296115 | Y_lesional_pre-dose | 1089.69 | 81 |
GSM1296084 | Z_lesional_pre-dose | 414.37 | 65 |
GSM1296072 | B_lesional_day8 | 668.07 | 73 |
GSM1296069 | L_lesional_day8 | 887.82 | 78 |
GSM1296071 | P_lesional_day8 | 741.92 | 74 |
GSM1296070 | Y_lesional_day8 | 837.56 | 77 |
GSM1296073 | V_lesional_day8 | 1081.29 | 80 |
GSM1296034 | A_lesional_day15 | 249.36 | 55 |
GSM1296041 | G_lesional_day15 | 982.15 | 79 |
GSM1296035 | R_lesional_day15 | 441.92 | 65 |
GSM1296038 | U_lesional_day15 | 541.46 | 69 |
GSM1296047 | B_lesional_day15 | 776.21 | 75 |
GSM1296039 | E_lesional_day15 | 733.15 | 75 |
GSM1296042 | H_lesional_day15 | 877.77 | 77 |
GSM1296043 | L_lesional_day15 | 828.62 | 76 |
GSM1296037 | M_lesional_day15 | 361.16 | 62 |
GSM1296046 | P_lesional_day15 | 831.54 | 76 |
GSM1296044 | Q_lesional_day15 | 916.6 | 78 |
GSM1296045 | Y_lesional_day15 | 849.81 | 77 |
GSM1296025 | C_lesional_day15 | 395.76 | 64 |
GSM1296033 | D_lesional_day15 | 474.78 | 67 |
GSM1296027 | I_lesional_day15 | 401.7 | 64 |
GSM1296032 | J_lesional_day15 | 432.09 | 65 |
GSM1296024 | K_lesional_day15 | 299.85 | 59 |
GSM1296031 | W_lesional_day15 | 470.49 | 66 |
GSM1296028 | X_lesional_day15 | 475.74 | 67 |
GSM1296029 | Z_lesional_day15 | 449.58 | 66 |
GSM1296026 | F_lesional_day15 | 357.01 | 63 |
GSM1296030 | O_lesional_day15 | 537.22 | 69 |
GSM1296040 | S_lesional_day15 | 308.2 | 59 |
GSM1296036 | T_lesional_day15 | 451.51 | 65 |
GSM1296048 | V_lesional_day15 | 853.09 | 77 |
GSM1296059 | A_lesional_day43 | 401.81 | 64 |
GSM1296066 | G_lesional_day43 | 880.3 | 77 |
GSM1296060 | R_lesional_day43 | 590.93 | 70 |
GSM1296063 | U_lesional_day43 | 724.83 | 74 |
GSM1296064 | E_lesional_day43 | 834.79 | 76 |
GSM1296067 | H_lesional_day43 | 673.75 | 72 |
GSM1296062 | M_lesional_day43 | 448.23 | 65 |
GSM1296068 | Q_lesional_day43 | 841.91 | 77 |
GSM1296050 | C_lesional_day43 | 803.28 | 76 |
GSM1296057 | D_lesional_day43 | 369.35 | 62 |
GSM1296052 | I_lesional_day43 | 330.89 | 61 |
GSM1296054 | J_lesional_day43 | 405.92 | 64 |
GSM1296049 | K_lesional_day43 | 548.81 | 69 |
GSM1296055 | W_lesional_day43 | 431.2 | 65 |
GSM1296053 | X_lesional_day43 | 361.07 | 62 |
GSM1296058 | Z_lesional_day43 | 159.5 | 49 |
GSM1296051 | F_lesional_day43 | 749.17 | 75 |
GSM1296056 | O_lesional_day43 | 463.37 | 67 |
GSM1296065 | S_lesional_day43 | 763.07 | 75 |
GSM1296061 | T_lesional_day43 | 449.02 | 65 |
GSM1296095 | A_non-lesional_pre-dose | 433.86 | 66 |
GSM1296120 | B_non-lesional_pre-dose | 807.73 | 76 |
GSM1296077 | C_non-lesional_pre-dose | 390.84 | 64 |
GSM1296093 | D_non-lesional_pre-dose | 314.7 | 59 |
GSM1296104 | E_non-lesional_pre-dose | 540.47 | 69 |
GSM1296079 | F_non-lesional_pre-dose | 576.67 | 70 |
GSM1296108 | G_non-lesional_pre-dose | 854.03 | 77 |
GSM1296110 | H_non-lesional_pre-dose | 638.89 | 71 |
GSM1296081 | I_non-lesional_pre-dose | 272.94 | 58 |
GSM1296091 | J_non-lesional_pre-dose | 559.88 | 70 |
GSM1296075 | K_non-lesional_pre-dose | 659.25 | 73 |
GSM1296112 | L_non-lesional_pre-dose | 754.78 | 75 |
GSM1296100 | M_non-lesional_pre-dose | 295.88 | 58 |
GSM1296087 | O_non-lesional_pre-dose | 460.2 | 67 |
GSM1296118 | P_non-lesional_pre-dose | 886.19 | 77 |
GSM1296114 | Q_non-lesional_pre-dose | 911.51 | 78 |
GSM1296097 | R_non-lesional_pre-dose | 562.17 | 70 |
GSM1296106 | S_non-lesional_pre-dose | 672.8 | 72 |
GSM1296102 | U_non-lesional_pre-dose | 292.54 | 57 |
GSM1296122 | V_non-lesional_pre-dose | 628.16 | 71 |
GSM1296089 | W_non-lesional_pre-dose | 523.15 | 68 |
GSM1296083 | X_non-lesional_pre-dose | 441.41 | 65 |
GSM1296116 | Y_non-lesional_pre-dose | 839.87 | 77 |
GSM1296085 | Z_non-lesional_pre-dose | 499.69 | 67 |